Gonçalves Lucio de Souza, Ferreira Sônia Maria Soares, Silva Arley, Villoria German Eduardo, Costinha Lúcia Helena, Colombo Ana Paula
Dental School, Federal University of Rio de Janeiro, Rio de Janeiro, R.J., Brazil.
J Periodontol. 2005 Jun;76(6):915-22. doi: 10.1902/jop.2005.76.6.915.
Controversial data regarding the association between immunosuppression and prevalence/ severity of periodontal diseases in HIV infection have been reported. Thus, the aim of this study was to test the hypothesis that lower T CD4 lymphocyte levels are not related to a higher prevalence of chronic periodontitis in HIV-infected Brazilians undergoing highly active anti-retroviral therapy (HAART).
Sixty-four HIV-infected patients under HAART were classified as having chronic periodontitis; i.e., > or = three sites with probing depth (PD) and/or clinical attachment level (CAL) > or = 5 mm or periodontal healthy (no sites with PD > 3 mm and/or CAL > 4 mm). All subjects received conventional periodontal therapy. Bleeding on probing, plaque accumulation, PD, and CAL were registered at six sites/tooth at baseline and 4 months after therapy. Epidemiological features and levels of T CD4 lymphocytes were obtained from medical records. Significance of differences in periodontal clinical parameters within and between groups were determined using Wilcoxon signed-rank and Mann-Whitney or independent sample t tests. Associations between T CD4 levels and clinical parameters were determined using the chi square test.
Sixty-one percent of the HIV-infected patients represented AIDS cases, although 69% of them were periodontally healthy. The overall T CD4 lymphocyte mean levels was 333 +/- 254 cells/mm3 and viral load was 12,815 +/- 24,607 copies/mm3. Yet the prevalence of chronic periodontitis was relatively low (36%). In addition, patients with periodontitis presented a moderate disease (mean PD = 2.2 +/- 0.10; mean CAL = 2.6 +/- 0.13) and responded successfully to periodontal therapy. These subjects showed higher levels of T CD4 cells, but lower counts of neutrophils than periodontally healthy patients. Among periodontally healthy and chronic periodontitis patients, 41.7% and 22.9%, respectively, had low levels of T CD4 lymphocytes. No significant differences between periodontal status and epidemiological and immunological parameters were observed.
Based on these results, the hypothesis that lower T CD4 lymphocyte levels are not associated with higher prevalence of chronic periodontitis in HIV-infected Brazilians under HAART cannot be rejected.
关于免疫抑制与HIV感染中牙周疾病患病率/严重程度之间的关联,已有存在争议的数据报道。因此,本研究的目的是检验以下假设:在接受高效抗逆转录病毒治疗(HAART)的巴西HIV感染者中,较低的T CD4淋巴细胞水平与慢性牙周炎的较高患病率无关。
64例接受HAART的HIV感染患者被分类为患有慢性牙周炎;即,有≥3个位点的探诊深度(PD)和/或临床附着丧失(CAL)≥5mm,或为牙周健康(无PD>3mm和/或CAL>4mm的位点)。所有受试者均接受常规牙周治疗。在基线时以及治疗后4个月,记录六个位点/每颗牙的探诊出血、菌斑堆积、PD和CAL情况。从病历中获取流行病学特征和T CD4淋巴细胞水平。使用Wilcoxon符号秩检验以及Mann-Whitney检验或独立样本t检验来确定组内和组间牙周临床参数差异的显著性。使用卡方检验确定T CD4水平与临床参数之间的关联。
61%的HIV感染患者为艾滋病病例,尽管其中69%的患者牙周健康。T CD4淋巴细胞的总体平均水平为333±254个细胞/mm³,病毒载量为12,815±24,607拷贝/mm³。然而,慢性牙周炎的患病率相对较低(36%)。此外,患有牙周炎的患者病情为中度(平均PD = 2.2±0.10;平均CAL = 2.6±0.13),并且对牙周治疗反应良好。这些受试者的T CD4细胞水平较高,但中性粒细胞计数低于牙周健康的患者。在牙周健康和慢性牙周炎患者中,分别有41.7%和22.9%的患者T CD4淋巴细胞水平较低。未观察到牙周状况与流行病学和免疫学参数之间存在显著差异。
基于这些结果,在接受HAART的巴西HIV感染者中,较低的T CD4淋巴细胞水平与慢性牙周炎较高患病率无关这一假设不能被推翻。